BioCentury | Nov 4, 2002
Finance

Ebb & Flow

...engineered proteins with antibody-like ligand binding properties. Fund watch Tullis-Dickerson raised $122 million for its Tullis-Dickerson Capital Focus III...
BioCentury | Oct 28, 2002
Financial News

Tullis-Dickerson closes fourth fund

...Tullis-Dickerson (Greenwich, Conn.) raised $122 million for its Tullis-Dickerson Capital Focus III (TD III), which will invest in seed...
Items per page:
1 - 2 of 2
BioCentury | Nov 4, 2002
Finance

Ebb & Flow

...engineered proteins with antibody-like ligand binding properties. Fund watch Tullis-Dickerson raised $122 million for its Tullis-Dickerson Capital Focus III...
BioCentury | Oct 28, 2002
Financial News

Tullis-Dickerson closes fourth fund

...Tullis-Dickerson (Greenwich, Conn.) raised $122 million for its Tullis-Dickerson Capital Focus III (TD III), which will invest in seed...
Items per page:
1 - 2 of 2